Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

151

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D10AD53	EPIDUO	B	Adapalene - 0.1%, Benzoyl peroxide - 2.5%		Gel	2,088,331 L.L
V03AE03	FOSRENOL	B	Lanthanum Carbonate - 500mg	500mg	Tablet, chewable	18,751,847 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.25mcg	0.25mcg	Capsule	1,138,235 L.L
C05AX05	PROCTO GLYVENOL	B	Lidocaine HCl - 2g/100g, Tribenoside - 5g/100g		Cream	405,840 L.L
D10AD53	EPIDUO FORTE	B	Adapalene - 0.3%, Benzoyl peroxide - 2.5%		Gel	2,201,214 L.L
J07BB02	INFLUVAC	B	Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml		Injectable suspension	573,821 L.L
L01EF01	IBRANCE	B	Palbociclib - 100mg	100mg	Capsule	172,164,216 L.L
L02BX03	ZYTIGA	B	Abiraterone acetate - 500mg	500mg	Tablet, film coated	72,384,396 L.L
N05CM18	PRECEDEX (DEXMEDETOMIDINE)	B	Dexmedetomidine HCl - 200mcg/2ml	200mcg/2ml	Injectable solution	19,441,512 L.L
V03AE03	FOSRENOL	B	Lanthanum Carbonate - 750mg	750mg	Tablet, chewable	24,138,283 L.L
A08AA01	LOMAIRA	B	Phentermine Hydrochloride - 8mg	8mg	Tablet	6,138,673 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	943,377 L.L
C05BA53	CONTRACTUBEX	B	Allantoin - 1g/100g, Cepae - 10g/100g, Heparin - 5000IU/100g		Gel	498,566 L.L
G04BE09	LEVITRA	B	Vardenafil (HCl) - 20mg	20mg	Tablet, film coated	2,660,808 L.L
J07BC01	ENGERIX-B 20	B	Hepatitis B, purified antigen - 20mcg/ml	20mcg/ml	Injectable suspension	1,652,926 L.L
L01EF01	IBRANCE	B	Palbociclib - 100mg	100mg	Tablet, film coated	172,164,216 L.L
M01AC01	BRUXICAM	B	Piroxicam - 0.5%		Drops solution	530,818 L.L
N01BB54	EMLA	B	Prilocaine - 25mg/g, Lidocaine - 25mg/g	5%	Cream	1,763,121 L.L
R06AB54	ALERGICAL EXPECTORANT	B	Chlorpheniramine maleate - 50mg/100ml, Guaifenesin - 2000mg/100ml, Dihydroxypropyltheophylline - 500mg/100ml, Paracetamol - 2000mg/100ml		Syrup	485,127 L.L
A08AA62	CONTRAVE	B	Naltrexone Hydrochloride - 8mg, Bupropion Hydrochloride - 90mg		Tablet, prolonged release	11,653,550 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 0.5mcg	0.5mcg	Capsule	942,034 L.L
C05BA53	CONTRACTUBEX	B	Allantoin - 1g/100g, Cepae - 10g/100g, Heparin - 5,000IU/100g		Gel	1,183,925 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 16mg	16mg	Tablet	705,517 L.L
J07BC01	ENGERIX-B 10	B	Hepatitis B, surface antigen - 10mcg/0.5ml	10mcg/0.5ml	Injectable suspension	1,042,822 L.L
M01AC01	BREXIN	B	Piroxicam-?-cyclodextrin - 20mg	20mg	Tablet, scored	971,598 L.L
V03AF01	UROMITEXAN	B	Mesna - 400mg/4ml	400mg/4ml	Injectable solution	2,632,587 L.L
A08AB01	XENICAL	B	Orlistat - 120mg	120mg	Capsule	4,036,903 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Drops solution	1,343,843 L.L
C05BB02	AETHOXYSKLEROL	B	Polidocanol (Lauromacrogol 400) - 0.5%	0.5%	Injectable solution	1,441,943 L.L
C09CA06	BLOPRESS	B	Candesartan cilexetil - 16mg	16mg	Tablet	1,131,515 L.L

...

151

...